GALE Stock Overview
Galenica AG operates as a healthcare service provider in Switzerland and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Galenica AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF70.55 |
| 52 Week High | CHF78.20 |
| 52 Week Low | CHF65.10 |
| Beta | 0.18 |
| 1 Month Change | -3.55% |
| 3 Month Change | -6.80% |
| 1 Year Change | -8.97% |
| 3 Year Change | 12.52% |
| 5 Year Change | 44.99% |
| Change since IPO | 64.07% |
Recent News & Updates
Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25
We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Recent updates
Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now
Jan 22Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?
Jan 04Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Oct 26Is Galenica (VTX:GALE) Using Too Much Debt?
Oct 11Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?
Sep 26These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Jun 20Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return
Apr 17We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt
Mar 12Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Jan 08These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Nov 28The Returns At Galenica (VTX:GALE) Aren't Growing
Sep 20Is Galenica (VTX:GALE) A Risky Investment?
Aug 30Return Trends At Galenica (VTX:GALE) Aren't Appealing
Jun 15Galenica (VTX:GALE) Could Easily Take On More Debt
Apr 06Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Feb 15Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?
Jan 02Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?
Nov 30Returns At Galenica (VTX:GALE) Appear To Be Weighed Down
Oct 24With EPS Growth And More, Galenica (VTX:GALE) Is Interesting
Sep 25Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Aug 24Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Jul 24If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late
Jun 12Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)
Apr 07Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Mar 25Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 11Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?
Feb 27Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?
Jan 31
Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain
Jan 13Is Galenica (VTX:GALE) Likely To Turn Things Around?
Dec 25Is Galenica (VTX:GALE) A Risky Investment?
Dec 09Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?
Nov 24Shareholder Returns
| GALE | CH Healthcare | CH Market | |
|---|---|---|---|
| 7D | -0.4% | 2.5% | -0.4% |
| 1Y | -9.0% | -4.7% | -4.5% |
Return vs Industry: GALE underperformed the Swiss Healthcare industry which returned -3.3% over the past year.
Return vs Market: GALE underperformed the Swiss Market which returned -4.2% over the past year.
Price Volatility
| GALE volatility | |
|---|---|
| GALE Average Weekly Movement | 2.0% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in CH Market | 7.4% |
| 10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: GALE has not had significant price volatility in the past 3 months.
Volatility Over Time: GALE's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 6,181 | Marc Werner | www.galenica.com |
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands.
Galenica AG Fundamentals Summary
| GALE fundamental statistics | |
|---|---|
| Market cap | CHF3.52b |
| Earnings (TTM) | CHF164.92m |
| Revenue (TTM) | CHF3.76b |
21.3x
P/E Ratio0.9x
P/S RatioIs GALE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GALE income statement (TTM) | |
|---|---|
| Revenue | CHF3.76b |
| Cost of Revenue | CHF3.29b |
| Gross Profit | CHF461.34m |
| Other Expenses | CHF296.43m |
| Earnings | CHF164.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 06, 2024
| Earnings per share (EPS) | 3.31 |
| Gross Margin | 12.28% |
| Net Profit Margin | 4.39% |
| Debt/Equity Ratio | 33.2% |
How did GALE perform over the long term?
See historical performance and comparison